Alternative data datasets
Browse by provider, category, marketplace, access, delivery and license
Tracks FDAAA Section 801 reporting adherence, ranks sponsor credibility, and surfaces trial-level risk signals.
Pharmacovigilance risk assessment scores tied to biological mechanisms, derived from FDA prescribing information, published research, and ongoing clinical studies.
Extensive United States pharmaceutical reference data is available to support regulatory, clinical safety, and research workflows.
Analyzing the Impact of the Pandemic on Low-Income Populations
View source information and access options.
View source information and access options.
View source information and access options.
View source information and access options.
View source information and access options.
View source information and access options.
View source information and access options.
View source information and access options.
A worldwide research resource built on de-identified records from more than 130 million patients to enable cohort identification.
A platform pooling electronic health record information from U.S. healthcare providers to support real-world evidence studies.
Clinical Trials Data Ingestion & ETL Pipeline -ClinicalTrials.gov API v2
Veeva CRM data capturing how life-sciences sales teams interact with healthcare professionals in the field.
Over 3.9 million healthcare and wellness sites featuring operational status, contact indicators, and coverage details.
Over 635,000 registered clinical studies from ClinicalTrials.gov together with a supplementary pharma intelligence table of roughly 1.06 million rows that map those trials to FDA drug approvals, distributed as part of an open data initiative for academic and personal use.